Short answer: Retatrutide has a half-life of about 6 days (Urva S, et al. 2022) and reaches steady state after about 30 days (~4.3 weeks) of regular dosing. We could not confirm a published time to peak for retatrutide, so we do not state one. On a weekly schedule the model builds up to about 1.8× a single dose, with a peak-to-trough swing of about 1.68:1.
Relative units: 1 on the scale is one full dose. There is no FDA label dose for this use, so the chart shows the shape of the curve, not an amount. Dashed line: 5 half-lives. Change the amount or schedule in the calculator.
We could not confirm a published time to peak for retatrutide, so we do not state one. The curve still needs a rise time, so it uses the app's modeling estimate; treat the shape of the first day or two as approximate.
With regular dosing at a fixed amount and interval, levels climb toward steady state by the same fraction every half-life, whatever the dose. At a half-life of about 6 days:
| Share of steady state | Half-lives | Time |
|---|---|---|
| 50% | 1 | 6 days |
| 75% | 2 | 12 days |
| 90% | 3.3 | 19.9 days |
| 97% (Dose Track's steady-state rule) | 5 | 30 days (~4.3 weeks) |
The longer the gap between doses compared with the half-life, the bigger the swing from peak to trough and the less the levels build up. These ratios do not depend on the amount.
| Interval | Peak : trough | Build-up vs one dose |
|---|---|---|
| Daily | 1.02 : 1 | 9.17× |
| Every other day | 1.07 : 1 | 4.85× |
| Twice weekly | 1.19 : 1 | 3.01× |
| Weekly | 1.68 : 1 | 1.8× |
| Every 2 weeks | 3.63 : 1 | 1.25× |
Build-up is the accumulation ratio 1 / (1 − e−k·τ), with k = ln 2 / half-life and τ the interval.
After the last dose, about half is gone every 6 days. After 5 half-lives, about 30 days (~4.3 weeks), roughly 97% has cleared in the model.
A phase 1b trial (Urva 2022) reported a half-life of about 6 days. We could not confirm a published time to peak, so we leave it out.
The curve uses the half-life, time to peak, route and bioavailability built into the Dose Track app for retatrutide, and the same one-compartment model with first-order absorption. These are modeled estimates from published half-lives, drawn with the same one-compartment model as the Dose Track app. Real levels vary from person to person, and only a lab test measures them. This is not medical advice and not a dosing recommendation; dosing decisions belong with you and your prescriber.
Vial sizes and syringe math are in the Retatrutide guide.
Semaglutide · Tirzepatide · Cagrilintide · Dulaglutide · Liraglutide · Testosterone Cypionate · Testosterone Propionate · hCG · Anastrozole · Exemestane · HGH · Tesamorelin · Ipamorelin · CJC-1295 with DAC · Thymosin Alpha-1
Half-life calculator · Compound guides · Reconstitution calculator